Skip to main content
Sponsored

Phage therapy and the future of global antimicrobial resistance

As antibiotic resistance increases, Armata Pharmaceuticals CEO Dr Deborah Birx shares how Armata is reimagining how we treat bacterial infections, pioneering novel phage therapy for greater clinical impact with minimal harm. Antimicrobial resistance (AMR) is rapidly becoming one of the greatest challenges faced by modern medicine, threatening to render current antibiotic treatments of bacterial infections … Continued